Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Carcinoma, Non-Small-Cell Lung 2Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Small Cell Lung Carcinoma 1Myeloproliferative Disorders 1Leukemia, Myeloid 1Leukemia 1Head and Neck Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Tobacco Use Cessation Devices 7Counseling 6Varenicline 4Nicotine Replacement Therapy 3Early Intervention, Educational 3Community Health Workers 3Bupropion 3Surveys and Questionnaires 2Nicotine 2Aspirin 2zileuton 1phenethyl isothiocyanate 1phenanthrene tetraol 1phenanthrene 1Zinc Oxide 1X-Rays 1Sulindac 1Spectroscopy, Fourier Transform Infrared 1Spectrometry, Fluorescence 1Risk Factors 1Radiotherapy 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Optical Imaging 1Nicotine Chewing Gum 1Molecular Diagnostic Techniques 1Methods 1Memantine 1Immunohistochemistry 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tobacco Use Disorder × zileuton × Clear all
NCT01021215 2015-04-02

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

National Cancer Institute (NCI)

Phase 1/2 Completed
84 enrolled 10 charts

Smoking, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡